Studies of immunological and microbiological efficiency of the therapy of curcumin and methionine in the developed capsules

Cover Page

Cite item

Abstract

Curcumin is a polyphenolic compound, the main component of the Curcuma longa rhizome. Recently, there is growing interest to studies of this new, inexpensive and safe substance that may be used to treat various diseases. Curcumin is widely used in medicine due to its therapeutic efficacy and safety. Its usage in therapeutic practice as a dietary supplement has shown that curcumin exhibits antioxidant and immunomodulatory effects. Data from clinical studies have shown its pharmacokinetic, pharmacodynamic profile and potential use of curcumin in humans for treatment of various diseases, even at the early stages of treatment. Purpose of the study: analysis of immunomodulatory and microbiological properties when using the original grained preparation containing curcumin and methionine. It is suggested to have a regulatory effect by modulating microbial richness, diversity and composition of intestinal microflora. Analysis of immunomodulatory and microbiological activity of the components in the developed dosage form of the capsules with curcumin and methionine was carried out in vitro and in vivo. Functional and metabolic properties of neutrophils were determined with addition of its components, i.e., curcumin and methionine. The analysis of intensity and activity of neutrophils was carried out using the NBT-test. The analysis showed that simultaneous incubation of peripheral blood neutrophils from ICR (CD-1) mice with curcumin and methionine leads to an increase in spontaneous and induced NBT-reducing activity, an increase in the functional reserve and phagocytic activity of peripheral blood neutrophils in mice. A study of the modulating effects of oral intake of curcumin and methionine, which are part of the dosage form, on the intestinal microbiota of ICR (CD-1) mice was carried out. It was found that curcumin, together with methionine, affects the number of some representative families of intestinal microbial communities: in total, there were 640 common operating taxonomic units. between the curcumin-methionine and control groups, 65 were unique in the curcumin-methionine group and 93 in the control group. Given the direct link between gut microbiota and certain diseases, these results may help to interpret therapeutic benefits of curcumin with methionine. The results of the study showed that the developed dosage form, which contains curcumin and methionine, shows antioxidant and immunomodulatory effects, which can be potentially used to treat diseases associated with the effects of oxidative stress on the organism.

About the authors

A. A. Khisamova

Peoples' Friendship University of Russia

Author for correspondence.
Email: Khisamova.ann@gmail.com

Anna A. Khisamova – Doctoral Student, Department of Microbiology and Virology, Peoples' Friendship University of Russia.

117049, Moscow, Miklukho-Maclay str., 8.

Phone: 7 (905) 837-47-55.

Russian Federation

O. A. Gizinger

Peoples' Friendship University of Russia

Email: fake@neicon.ru

PhD, MD (Biology), Professor, Department of Microbiology and Virology, Medical Institute, Peoples' Friendship University of Russia.

117049, Moscow, Miklukho-Maclay str., 8.

Russian Federation

N. V. Kornova

South Ural State Medical University

Email: versache-k@mail.ru

Natalya V. Kornova - PhD (Medicine), Assistant Professor,  Department of Otorhinolaryngology, South Ural State Medical University.

Chelyabinsk.

Russian Federation

K. S. Zyryanova

South Ural State Medical University

Email: Khisamova.ann@gmail.com

Kira S. Zyryanova - PhD (Medicine), Assistant Professor, Department of Otorhinolaryngology, South Ural State Medical University.

Chelyabinsk.

Russian Federation

A. M. Korkmazov

South Ural State Medical University

Email: fake@neicon.ru

Arsen M. Korkmazov - PhD (Medicine), Assistant Professor, Department of Otorhinolaryngology, South Ural State Medical University.

Chelyabinsk.

Russian Federation

A. S. Beloshangin

South Ural State Medical University

Email: Khisamova.ann@gmail.com

Artem S. Beloshangin - PhD (Medicine), Assistant Professor, Department of Otorhinolaryngology, South Ural State Medical University.

Chelyabinsk.

Russian Federation

References

  1. Виксман М.Е., Маянский А.Н. Способ оценки функциональной активности нейтрофилов человека по реакции восстановления нитросинего тетразолия: Методические рекомендации. Казань, 1979. 14 с.
  2. Гизингер О.А., Долгушин И.И., Летяева О.И. Исследование дегрануляционных возможностей нейтрофилов при их облучении лазером низкой плотности in vitro // Вестник уральской медицинской академической науки, 2010. Т. 4, № 32. С. 23-26.
  3. Гизингер О.А., Хисамова А.А. Биофармацевтические исследования при разработке лекарственной формы с метионином и экстрактом куркумы длинной (Curcuma longa) // Разработка и регистрация лекарственных средств, 2021, Т. 10, № 2. С. 24-30.
  4. Гизингер О.А., Симонян Е.В., Хисамова А.А. Способ получения лекарственного средства с метионином и экстрактом куркумы в виде гранул с кишечнорастворимым покрытием системного действия. RU 2 684 111 C1 от 07.02.2018.
  5. Государственная фармакопея СССР. 11-е изд. Вып. 1. Общие методы анализа. М.: Медицина,1987. 336 с.
  6. Симонян А.В., Саламатов А.А., Покровская Ю.С., Аванесян А.А. Использование нингидриновой реакции для количественного определения а-аминокислот в различных объектах: методические рекомендации. Волгоград, 2007. 106 с.
  7. Aledo J.C. Methionine in proteins: The Cinderella of the proteinogenic amino acids. Protein Sci., 2019, Vol. 28, no. 10, pp. 1785-1796.
  8. Annuzzi G., Bozzetto L., Costabile G., Giacco R., Mangione A., Anniballi G., Vitale M., Vetrani C., Cipriano P., Della Corte G., Pasanisi F., Riccardi G., Rivellese A.A. Diets naturally rich in polyphenols improve fasting and postprandial dyslipidemia and reduce oxidative stress: a randomized controlled trial. Am. J. Clin. Nutr., 2014, Vol. 99, pp. 463-471.
  9. Arora T., Backhed F. The gut microbiota and metabolic disease: current understanding and future perspectives. J. Intern. Med., 2016, Vol. 280, pp. 339-349.
  10. Estrela J.M., Mena S., Obrador E., Benlloch M., Castellano G., Salvador R., Dellinger R.W. Polyphenolic phytochemicals in cancer prevention and therapy: bioavailability versus bioefficacy. J. Med. Chem., 2017, Vol. 60, pp. 9413-9436.
  11. Feng W., Wang H., Zhang P., Gao C., Tao J., Ge Z., Zhu D., Bi Y. Modulation of gut microbiota contributes to curcumin-mediated attenuation of hepatic steatosis in rats. Biochim. Biophys. Acta, 2017, Vol. 1861, pp. 1801-1812.
  12. le Chatelier E., Nielsen T., Qin J., Prifti E., Hildebrand F., Falony G., Almeida M., Arumugam M., Batto J.M., Kennedy S., et al. Richness of human gut microbiome correlates with metabolic markers. Nature, 2013, Vol. 500, pp. 541-546.
  13. Martinez Y., Li X., Liu G., Bin P., Yan W., Mas D., Valdivie M., Hu C.A., Ren W., Yin Y. The role of methionine on metabolism, oxidative stress, and diseases. Amino Acids, 2017, Vol. 49, no. 12, pp. 2091-2098.
  14. Massier L., Bluher M., Kovacs P, Chakaroun R.M. Impaired intestinal barrier and tissue bacteria: pathomechanisms for metabolic diseases. Front. Endocrinol. (Lausanne), 2021, Vol. 9, no. 12, 616506. doi: 10.3389/fendo.2021.616506.
  15. McFadden R.M., Larmonier C.B., Shehab K.W., Midura-Kiela M., Ramalingam R., Harrison C.A., Besselsen D.G., Chase J.H., Caporaso J.G., Jobin C., et al. The role of curcumin in modulating colonic microbiota during colitis and colon cancer prevention. Inflamm. Bowel Dis., 2015, Vol. 21, pp. 2483-2494.
  16. Mohammed A., Islam M.S. Spice-derived bioactive ingredients: potential agents or food adjuvant in the management of diabetes mellitus. Front. Pharmacol., 2018, Vol. 22, no. 9, 893. doi: 10.3389%2Ffphar.2018.00893.
  17. Momtazi-Borojeni A.A., Haftcheshmeh S.M., Esmaeili S.-A., Johnston T.P., Abdollahi E., Sahebkar A. Curcumin: A natural modulator of immune cells in systemic lupus erythematosus. Autoimmun. Rev., 2018, Vol. 17, pp. 125-135.
  18. Nilius B., Appendino G. Spices: the savory and beneficial science of pungency. Rev. Physiol. Biochem. Pharmacol., 2013, Vol. 64, pp. 1-76.
  19. Oniszczuk A., Oniszczuk T., Gancarz M., Szymanska J. Role of gut microbiota, probiotics and prebiotics in the cardiovascular diseases. Molecules, 2021, Vol. 26, no. 4, 1172. doi: 10.3390%2Fmolecules26041172.
  20. Shen L., Ji H.F. Intestinal microbiota and metabolic diseases: pharmacological implications. Trends Pharmacol. Sci., 2016, Vol. 37, pp. 169-171.
  21. Shen L., Liu L., Ji H.F. Regulative effects of curcumin spice administration on gut microbiota and its pharmacological implications. Food Nutr. Res., 2017, Vol. 61, 1361780. doi: 10.1080/16546628.2017.1361780.
  22. Vogel H.A., Pelletier J. Curcumin-biological and medicinal properties. J. Pharm., 1815, Vol. 2, 50. doi: 10.3390%2Fmolecules24162930.

Supplementary files

There are no supplementary files to display.


Copyright (c) 2021 Khisamova A.A., Gizinger O.A., Kornova N.V., Zyryanova K.S., Korkmazov A.M., Beloshangin A.S.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
Свидетельство о регистрации СМИ ПИ № 77 - 11525 от 04.01.2002 выдано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies